209 related articles for article (PubMed ID: 24036547)
1. Somatic inactivation of Tp53 in hematopoietic stem cells or thymocytes predisposes mice to thymic lymphomas with clonal translocations.
DeMicco A; Yang-Iott K; Bassing CH
Cell Cycle; 2013 Oct; 12(20):3307-16. PubMed ID: 24036547
[TBL] [Abstract][Full Text] [Related]
2. Tp53 deletion in B lineage cells predisposes mice to lymphomas with oncogenic translocations.
Rowh MA; DeMicco A; Horowitz JE; Yin B; Yang-Iott KS; Fusello AM; Hobeika E; Reth M; Bassing CH
Oncogene; 2011 Nov; 30(47):4757-64. PubMed ID: 21625223
[TBL] [Abstract][Full Text] [Related]
3. Aberrant V(D)J recombination is not required for rapid development of H2ax/p53-deficient thymic lymphomas with clonal translocations.
Bassing CH; Ranganath S; Murphy M; Savic V; Gleason M; Alt FW
Blood; 2008 Feb; 111(4):2163-9. PubMed ID: 17855626
[TBL] [Abstract][Full Text] [Related]
4. Somatic inactivation of ATM in hematopoietic cells predisposes mice to cyclin D3 dependent T cell acute lymphoblastic leukemia.
Ehrlich LA; Yang-Iott K; DeMicco A; Bassing CH
Cell Cycle; 2015; 14(3):388-98. PubMed ID: 25659036
[TBL] [Abstract][Full Text] [Related]
5. Cellular context-dependent effects of H2ax and p53 deletion on the development of thymic lymphoma.
Yin B; Yang-Iott KS; Chao LH; Bassing CH
Blood; 2011 Jan; 117(1):175-85. PubMed ID: 20947684
[TBL] [Abstract][Full Text] [Related]
6. Conditional inactivation of p53 in mature B cells promotes generation of nongerminal center-derived B-cell lymphomas.
Gostissa M; Bianco JM; Malkin DJ; Kutok JL; Rodig SJ; Morse HC; Bassing CH; Alt FW
Proc Natl Acad Sci U S A; 2013 Feb; 110(8):2934-9. PubMed ID: 23382223
[TBL] [Abstract][Full Text] [Related]
7. Redundant and nonredundant functions of ATM and H2AX in αβ T-lineage lymphocytes.
Yin B; Lee BS; Yang-Iott KS; Sleckman BP; Bassing CH
J Immunol; 2012 Aug; 189(3):1372-9. PubMed ID: 22730535
[TBL] [Abstract][Full Text] [Related]
8. Combined deletion of Xrcc4 and Trp53 in mouse germinal center B cells leads to novel B cell lymphomas with clonal heterogeneity.
Chen Z; Elos MT; Viboolsittiseri SS; Gowan K; Leach SM; Rice M; Eder MD; Jones K; Wang JH
J Hematol Oncol; 2016 Jan; 9():2. PubMed ID: 26740101
[TBL] [Abstract][Full Text] [Related]
9. PARP1 and DNA-PKcs synergize to suppress p53 mutation and telomere fusions during T-lineage lymphomagenesis.
Rybanska I; Ishaq O; Chou J; Prakash M; Bakhsheshian J; Huso DL; Franco S
Oncogene; 2013 Apr; 32(14):1761-71. PubMed ID: 22614020
[TBL] [Abstract][Full Text] [Related]
10. Tumor suppression: putting p53 in context.
Mills KD
Cell Cycle; 2013 Nov; 12(22):3461-2. PubMed ID: 24131920
[No Abstract] [Full Text] [Related]
11. Tcrδ translocations that delete the Bcl11b haploinsufficient tumor suppressor gene promote atm-deficient T cell acute lymphoblastic leukemia.
Ehrlich LA; Yang-Iott K; Bassing CH
Cell Cycle; 2014; 13(19):3076-82. PubMed ID: 25486566
[TBL] [Abstract][Full Text] [Related]
12. Deletion of Irf5 protects hematopoietic stem cells from DNA damage-induced apoptosis and suppresses γ-irradiation-induced thymic lymphomagenesis.
Bi X; Feng D; Korczeniewska J; Alper N; Hu G; Barnes BJ
Oncogene; 2014 Jun; 33(25):3288-97. PubMed ID: 23912454
[TBL] [Abstract][Full Text] [Related]
13. Histone H2AX: a dosage-dependent suppressor of oncogenic translocations and tumors.
Bassing CH; Suh H; Ferguson DO; Chua KF; Manis J; Eckersdorff M; Gleason M; Bronson R; Lee C; Alt FW
Cell; 2003 Aug; 114(3):359-70. PubMed ID: 12914700
[TBL] [Abstract][Full Text] [Related]
14. Splenic marginal zone B-cell and thymic T-cell lymphomas in p53-deficient mice.
Ward JM; Tadesse-Heath L; Perkins SN; Chattopadhyay SK; Hursting SD; Morse HC
Lab Invest; 1999 Jan; 79(1):3-14. PubMed ID: 9952106
[TBL] [Abstract][Full Text] [Related]
15. Molecular analysis of cutaneous B- and T-cell lymphomas.
Neri A; Fracchiolla NS; Roscetti E; Garatti S; Trecca D; Boletini A; Perletti L; Baldini L; Maiolo AT; Berti E
Blood; 1995 Oct; 86(8):3160-72. PubMed ID: 7579411
[TBL] [Abstract][Full Text] [Related]
16. AID produces DNA double-strand breaks in non-Ig genes and mature B cell lymphomas with reciprocal chromosome translocations.
Robbiani DF; Bunting S; Feldhahn N; Bothmer A; Camps J; Deroubaix S; McBride KM; Klein IA; Stone G; Eisenreich TR; Ried T; Nussenzweig A; Nussenzweig MC
Mol Cell; 2009 Nov; 36(4):631-41. PubMed ID: 19941823
[TBL] [Abstract][Full Text] [Related]
17. The nuclear effector of Wnt-signaling, Tcf1, functions as a T-cell-specific tumor suppressor for development of lymphomas.
Tiemessen MM; Baert MR; Schonewille T; Brugman MH; Famili F; Salvatori DC; Meijerink JP; Ozbek U; Clevers H; van Dongen JJ; Staal FJ
PLoS Biol; 2012; 10(11):e1001430. PubMed ID: 23185135
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic role of Pax5 in the T-lymphoid lineage upon ectopic expression from the immunoglobulin heavy-chain locus.
Souabni A; Jochum W; Busslinger M
Blood; 2007 Jan; 109(1):281-9. PubMed ID: 16968900
[TBL] [Abstract][Full Text] [Related]
19. Genetic pathway to recurrent chromosome translocations in murine lymphoma involves V(D)J recombinase.
Vanasse GJ; Halbrook J; Thomas S; Burgess A; Hoekstra MF; Disteche CM; Willerford DM
J Clin Invest; 1999 Jun; 103(12):1669-75. PubMed ID: 10377173
[TBL] [Abstract][Full Text] [Related]
20. [Analyses of the rearrangement of T-cell receptor- and immunoglobulin genes in the diagnosis of lymphoproliferative disorders].
Griesser DH
Veroff Pathol; 1995; 144():1-109. PubMed ID: 7856305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
